Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is tacrolimus effective for treating antisynthetase-associated interstitial lung disease?

Nature Clinical Practice Rheumatology volume 1, pages 80–81 (2005)Cite this article

boxed-textWilkes MR et al. (2005) Treatment of antisynthetase-associated interstitial lung disease with tacrolimus. Arthritis Rheum 52: 2439–2446

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. American Thoracic Society and European Respiratory Society (2001) International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165: 277–304

  2. Douglas WW et al. (2001) Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 164: 1182–1185

    Article  CAS  Google Scholar 

  3. King TE Jr et al. (2005) Analyses of efficacy end points in a controlled trial of interferon-γ1b for idiopathic pulmonary fibrosis. Chest 127: 171–177

    Article  CAS  Google Scholar 

  4. Nicholson AG et al. (2000) The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 162: 2213–2217

    Article  CAS  Google Scholar 

  5. Ramos C et al. (2001) Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. Am J Respir Cell Mol Biol 24: 591–598

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Division of Rheumatology,

    Tim Bongartz, Jay H Ryu & Eric L Matteson

  2. Mayo Clinic in Rochester, USA

    Tim Bongartz, Jay H Ryu & Eric L Matteson

Authors
  1. Tim Bongartz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jay H Ryu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eric L Matteson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tim Bongartz.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bongartz, T., Ryu, J. & Matteson, E. Is tacrolimus effective for treating antisynthetase-associated interstitial lung disease?. Nat Rev Rheumatol 1, 80–81 (2005). https://doi.org/10.1038/ncprheum0067

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0067

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing